Combined treatment with thalidomide, corticosteroids, and erythropoietin in patients with idiopathic myelofibrosis

Eur J Haematol. 2005 Mar;74(3):273-4. doi: 10.1111/j.1600-0609.2004.00386.x.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Child, Preschool
  • Drug Therapy, Combination
  • Erythropoietin / therapeutic use
  • Female
  • Humans
  • Infant
  • Male
  • Primary Myelofibrosis / complications
  • Primary Myelofibrosis / drug therapy*
  • Primary Myelofibrosis / etiology
  • Remission Induction / methods
  • Thalidomide / therapeutic use
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Erythropoietin
  • Thalidomide